Skip to main content
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of Bone.
Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities.
Utility of Human-Derived Models for Glioblastoma.
Clonal Selection with RAS Pathway Activation Mediates Secondary Clinical Resistance to Selective FLT3 Inhibition in Acute Myeloid Leukemia.
Tissue-Specific Oncogenic Activity of KRASA146T.
Genome-Informed Targeted Therapy for Osteosarcoma.
The genetics of splicing in neuroblastoma.
Dominant role of oncogene dosage and absence of tumor suppressor activity in Nras-driven hematopoietic transformation.
FGFR fusions in the driver's seat.
G34, another connection between MYCN and a pediatric tumor.